Search for: "Aventis Pharmaceuticals, Inc."
Results 1 - 20
of 219
Sorted by Relevance
|
Sort by Date
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
26 Dec 2010, 9:59 pm
Sandoz, Inc., the Federal Circuit vacated the entry of a consent judgment and an injunction by the District Court for the District of New Jersey, which enjoined Defendants-Appellants Sun Pharmaceutical Industries, Ltd. and Caraco Pharmaceutical Laboratories, Ltd. [read post]
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and counterclaims by… [read post]
12 Sep 2007, 9:48 am
Inc. and sanofi-aventis U.S. [read post]
8 Oct 2008, 4:56 am
The '814 patent, which is owned by Defendant-Appellee Aventis Pharmaceuticals Inc., relates to the use of riluzole to treat amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's disease. [read post]
3 Jun 2013, 9:59 pm
Inc. v. [read post]
13 Feb 2008, 12:49 pm
Click here to read the Allamericanpatriots.com article Aventis Pharmaceuticals Inc. [read post]
2 Jun 2009, 2:56 pm
The Department of Justice announced last week that it has entered into a multi-million dollar civil settlement agreement with Aventis Pharmaceutical, Inc., a subsidiary of Sanofi Aventis U.S. [read post]
9 Feb 2007, 11:37 am
Singer In a February 9, 2007 press release, Sanofi-Aventis announced that it has lost its patent infringement suit against generic drugmakers Amphastar Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd., filed in the U.S. [read post]
2 Aug 2023, 11:05 am
The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. [read post]
19 Feb 2008, 1:23 am
The three United States patents at issue, which cover syringes having needle shield safety devices and may be used with pre-filled pharmaceutical injection syringes, are owned by Saftey Syringes, Inc. [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendant: Breckenridge Pharmaceutical, Inc. [read post]
10 Sep 2007, 10:41 pm
Aventis Pharmaceuticals Inc. has settled a lawsuit to resolve allegations that it fraudulently priced and marketed an antiemetic drug, Anzemet, causing false claims to be filed with Medicare and other federal health programs. [read post]
30 Aug 2009, 9:43 pm
LLC • Defendants: Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd. [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
25 Jun 2021, 4:15 am
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
30 Apr 2014, 10:00 pm
Glenmark Pharmaceuticals Inc., USA, addresses several interesting issues, but is most likely to be cited by other patent holders for its affirmance of the jury verdict that upheld the Tarka patent at issue. [read post]
12 Sep 2021, 9:59 pm
Amphastar Pharms., Inc., 525 F.3d 1334, 1349 (Fed. [read post]
14 Dec 2006, 6:47 am
Proof of efficacy is not required for a prior art reference to be enabling for purposes of anticipation. [read post]
